Monochromatic infrared energy (MIRE) is the process of delivering photo energy to the layers of the skin via lightemitting diodes placed externally on the skin. 1 This energy stimulates the microcirculation in the tissues to increase blood flow and to release free radical nitric oxide, 2 which helps to form cell receptors for growth factors and angiogenesis, and augments collagen formation in healing wounds. 3 The use of MIRE therapy is contraindicated in patients who have an active cancer or who are pregnant. 1 Monochromatic infrared energy has been used to treat a variety of wounds, including venous ulcers, diabetic ulcers, and recalcitrant dermal lesions. 2 Few studies have been published in the literature using infrared therapy alone for wounds. However, several studies have looked at the effects of MIRE in reversing diabetic peripheral neuropathy. Although these studies found positive improvement in peripheral neuropathy, none of the studies assessed the long-term effectiveness of MIRE therapy, and some of the studies had a small number of participants. [4] [5] [6] Clifft et al 7 conducted a double-blind, placebo-controlled study that compared active MIRE therapy with placebo MIRE therapy for 4 weeks. Participants were followed for another 4 weeks without treatment. When sensory impairment was assessed, the researchers found that improvements occurred during the 4-week active phase of MIRE therapy, but no significant improvements occurred during the 4-week posttreatment time. 7 In a retrospective cohort study of 68 individuals, aged 64 years and older with diabetic peripheral neuropathy, loss of protective sensation, and undergoing treatment with MIRE, researchers found a 1.5% incidence of new diabetic foot wounds. 8 This is less than the reported 7.3% estimated annual incidence of new diabetic foot wounds among the Medicare-aged population. 8 This study lacked a control group, and the incidence of diabetic wounds was via selfreport, thus conclusions should be examined with caution.
Clearly, more randomized controlled clinical trials are needed to determine if MIRE therapy heals wounds or improves diabetic peripheral neuropathy. One poster at the 2005 Clinical Symposium on Advances in Skin & Wound Care discussed this topic.
Use of Infrared Therapy to Enhance Healing of Chronic Wounds
Mary Foote, RN, MSN, CANP, CWCN, EdDc; Mary Purvin, RN, FNPc; and Linda Salitore, RN, WCC, Woundcare on Wheels, Inc, Naperville, IL OBJECTIVES: 1. Identify common elements of a chronic wound regardless of underlying comorbid conditions. 2. Describe how infrared therapy impacts cell function and wound healing. 3. State the benefits of utilization of this form of therapy as an adjunct to the healing process.
Chronic wounds, commonly referred to as refractory wounds, affect approximately 4 million people in the United States annually. This reflects 14% to 23% of patients with a wound etiology, and varies depending on their health care setting. Chronic wounds are costly with the repeated need for antibiotic intervention and/or recurrent hospital or skilled facility placement. This drains the finances of the family, not to mention the third-party payer. Conventional topical treatments may be ineffective in the management of chronic wounds, particularly if patients experience exacerbations of underlying autoimmune disease, arthritis, unstable diabetes with micro-occlusion to their extremities, or underlying infections that may not be responsive to antibiotic therapy. This poster will present the significant role of infrared therapy to the enhancement of healing where conventional therapies have failed. Infrared therapy delivers monochromatic photo energy through light-emitting diodes on the skin. The light that is emitted penetrates below the surface of the skin and is absorbed by target tissue. The photo energy releases a free radical molecule called nitric oxide. Nitric oxide causes relaxation in smooth muscle cells, allowing for increased circulation, promoting cell division and proliferation, collagen synthesis, collagen fibril alignment, and angiogenesis. The first infrared therapy treatment begins the release of nitric oxide, and subsequent treatments build on the physiologic and biochemical changes. Because new blood vessels progressively develop, healed wounds do not recur. Contraindications for use are active cancer with cell proliferation or pregnancy. Patients selected for this presentation reflect a duration of nonhealing from a minimum of 6 months to 15 years. The response of infrared therapy will be described in 4 diverse cases. The first case encompasses a long-term diabetic patient with peripheral neuropathy, lymphedema, osteomyelitis, MRSA, VRE, and immunosuppression due to a kidney transplant that presents with wounds to the heel and gaiter region. The second case describes the response of an MS, bed-bound patient with MRSA and cellulitis. The third case represents a patient with full-thickness pressure wounds with severe pain. The fourth case describes a severe arthritic patient with a history of PVD, COPD, and recurrent episodes of cellulitis. In each case, the patient received infrared therapy over a 30-minute timeframe, 2 to 5 times a week, coupled with a topical treatment of the clinician's choice.
In each case, the patient experienced decreased pain, edema, and reoccurrence of infection, along with decreased rehospitalization. The patient also experienced increased wound contraction and granulation on a consistent ongoing basis. Use of the infrared therapy had decreased the need for antibiotic therapy, pharmaceuticals for pain and neuropathic management, frequency in clinician intervention, and product utilization. Given the mobile nature of the therapy, the use of infrared therapy was not limited to a par-ticular setting, and was efficacious in the management of the bed-bound patient. This treatment has been shown to be a cost-saving, safe, and noninvasive adjunct to the management of chronic wounds. & Get fast news updates on the latest developments in the skin and wound care field.
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